About the Company
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
799
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SRNE News
Judge Declines to Dismiss Sorrento Therapeutics Bankruptcy Case
A Texas bankruptcy judge denied the Justice Department’s motion seeking to dismiss or transfer the Sorrento Therapeutics ...
Judge Rejects Bankruptcy Fraud Claims Against Sorrento Therapeutics Lawyers
Houston bankruptcy judge Christopher Lopez ruled that setting up a bank account and mailbox as a basis to file in Texas ...
Sorrento Defeats DOJ Effort to Move Bankruptcy Out of Texas (1)
A Texas judge ruled that Sorrento Therapeutics Inc. can keep its bankruptcy case in Houston following a dispute over the ...
Sorrento’s Bankruptcy Venue Action Is ‘Unprecedented,’ DOJ Says
The Justice Department’s bankruptcy watchdog doubled down on accusations of venue shopping against drug developer Sorrento Therapeutics Inc., calling its use of a days-old P.O. Box and bank account to ...
Sorrento wins DoJ’s venue-based challenge to bankruptcy filing
A U.S. bankruptcy court rejected the U.S. Justice Department's claims that Sorrento Therapeutics (SRNEQ) falsified its ...
Scilex Pharma Enters Definitive Mutual Release And Settlement Agreement With Virpax
Scilex Holding Company (SCLX) said the U.S. Bankruptcy Court for the Southern District of Texas, in connection with the bankruptcy ...
Sorrento Therapeutics files patent for stable oral liquid pharmaceutical composition of celecoxib for pain relief
Experience rapid pain relief with Sorrento Therapeutics' stable oral liquid pharmaceutical composition of celecoxib. Patent filed for effective pain management within 2 hours.
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
Virpax ® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...
Biotech bankruptcies hit a record despite sector’s recovery
Even as investors flocked to buy biotech stocks last year after two years of neglect, more biotech firms filed for Chapter 11 bankruptcy than any other year since 2010, the industry publication Fierce ...
Biotech bankruptcies: what to expect in 2024 following a record year?
2023 was a year of economic uncertainty for the biotech industry, which led to a funding drought. It also held the record for ...
SCLX Apr 2024 1.000 put
Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect ...
Amazon must face narrowed lawsuit over eBook prices, US judge says
A federal judge on Monday heavily trimmed an antitrust lawsuit that accused Amazon.com and others of causing consumers to ...
Loading the latest forecasts...